Hemodynamic effects of antihypertensive agents.
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001581:Benzothiadiazines; D002302:Cardiac Output / Q000187:drug effects; D003000:Clonidine / Q000009:adverse effects; D004232:Diuretics; D005500:Follow-Up Studies; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000009:adverse effects; D008297:Male; D008750:Methyldopa / Q000009:adverse effects; D008875:Middle Aged; D012306:Risk; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects; D013318:Stroke Volume / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D008750:Methyldopa; D003000:Clonidine; D007741:Labetalol